Moderna, Inc. (MRNA)
39.62
+5.78
(+17.08%)
USD |
NASDAQ |
Jan 13, 16:00
39.50
-0.12
(-0.30%)
After-Hours: 18:40
Moderna Free Cash Flow: -2.663B for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Eli Lilly & Co. | 6.436B |
| Merck & Co., Inc. | 13.05B |
| Pfizer Inc. | 10.38B |
| Novavax, Inc. | -384.71M |
| Johnson & Johnson | 20.46B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -847.00M |
| Cash from Investing (Quarterly) | 700.00M |
| Cash from Financing (Quarterly) | -1.00M |
| Free Cash Flow Per Share (Quarterly) | -2.256 |
| Free Cash Flow to Equity (Quarterly) | -873.00M |
| Free Cash Flow to Firm (Quarterly) | -880.00M |
| Free Cash Flow Yield | -17.36% |